Drugs that boost the immune organization have saved the lives of some males with terminal prostate cancer, suppose physicians in the UK.
The team at the Institute of Cancer Research and the Royal Marsden Hospital in London said the results were “spectacular” and a “big deal”.
However, the therapy will not work for most patients.
Cancer Research UK said the next step was to predict who would respond.
Immunotherapy is transforming the medicine of cancer and is now part of routine rule for some scalp and lung cancers.